Map3k5 Rat (1->4)-beta-D-glucan multiple interactions ISO Map3k5 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of MAP3K5 mRNA CTD PMID:36331819 Map3k5 Rat (S)-naringenin increases expression ISO MAP3K5 (Homo sapiens) 6480464 naringenin results in increased expression of MAP3K5 protein CTD PMID:27838343 Map3k5 Rat 1,2-dimethylhydrazine increases expression ISO Map3k5 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in increased expression of MAP3K5 mRNA CTD PMID:22206623 Map3k5 Rat 1,4-dithiothreitol multiple interactions ISO MAP3K5 (Homo sapiens) 6480464 Dithiothreitol inhibits the reaction [NCX 4040 inhibits the reaction [TXN1 protein binds to MAP3K5 protein]] CTD PMID:18922898 Map3k5 Rat 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine increases phosphorylation ISO Map3k5 (Mus musculus) 6480464 1-Methyl-4-phenyl-1 more ... CTD PMID:28939911 Map3k5 Rat 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine multiple interactions ISO Map3k5 (Mus musculus) 6480464 CIB1 gene mutant form promotes the reaction [1-Methyl-4-phenyl-1 more ... CTD PMID:28939911 Map3k5 Rat 17beta-estradiol multiple interactions ISO MAP3K5 (Homo sapiens) 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of MAP3K5 mRNA and [Estradiol co-treated with TGFB1 protein] results in decreased expression of MAP3K5 mRNA CTD PMID:19619570 and PMID:30165855 Map3k5 Rat 17beta-estradiol affects expression EXP 6480464 Estradiol affects the expression of MAP3K5 mRNA CTD PMID:32145629 Map3k5 Rat 17beta-estradiol multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of MAP3K5 mRNA CTD PMID:26496021 Map3k5 Rat 17beta-estradiol increases expression ISO MAP3K5 (Homo sapiens) 6480464 Estradiol results in increased expression of MAP3K5 mRNA CTD PMID:19619570 Map3k5 Rat 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO Map3k5 (Mus musculus) 6480464 2 more ... CTD PMID:25639565 Map3k5 Rat 2,2',4,4'-Tetrabromodiphenyl ether multiple interactions ISO Map3k5 (Mus musculus) 6480464 troxerutin inhibits the reaction [2 more ... CTD PMID:25639565 Map3k5 Rat 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO MAP3K5 (Homo sapiens) 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of MAP3K5 mRNA CTD PMID:19619570 Map3k5 Rat 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Map3k5 (Mus musculus) 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of MAP3K5 mRNA CTD PMID:25975270 Map3k5 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO MAP3K5 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin affects the expression of MAP3K5 mRNA CTD PMID:22574217 Map3k5 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO MAP3K5 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in decreased expression of MAP3K5 mRNA CTD PMID:19619570 Map3k5 Rat 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 Map3k5 Rat 2-hydroxypropanoic acid decreases expression ISO MAP3K5 (Homo sapiens) 6480464 Lactic Acid results in decreased expression of MAP3K5 mRNA CTD PMID:30851411 Map3k5 Rat 3-methyladenine affects response to substance ISO MAP3K5 (Homo sapiens) 6480464 3-methyladenine affects the susceptibility to MAP3K5 protein CTD PMID:20929985 Map3k5 Rat 3-methyladenine multiple interactions ISO MAP3K5 (Homo sapiens) 6480464 3-methyladenine inhibits the reaction [MAP3K5 protein results in decreased phosphorylation of MTOR protein] more ... CTD PMID:20929985 Map3k5 Rat 4,4'-sulfonyldiphenol increases expression ISO Map3k5 (Mus musculus) 6480464 bisphenol S results in increased expression of MAP3K5 mRNA CTD PMID:30951980 Map3k5 Rat 4-hydroxyphenyl retinamide increases expression ISO Map3k5 (Mus musculus) 6480464 Fenretinide results in increased expression of MAP3K5 mRNA CTD PMID:28973697 Map3k5 Rat 4-nitrophenol decreases expression ISO Map3k5 (Mus musculus) 6480464 4-nitrophenol results in decreased expression of MAP3K5 mRNA CTD PMID:34673133 Map3k5 Rat 4-phenylbutyric acid decreases expression ISO MAP3K5 (Homo sapiens) 6480464 4-phenylbutyric acid results in decreased expression of MAP3K5 protein CTD PMID:29444456 Map3k5 Rat 4-phenylbutyric acid multiple interactions ISO MAP3K5 (Homo sapiens) 6480464 4-phenylbutyric acid inhibits the reaction [Cadmium Chloride results in increased expression of MAP3K5 protein] CTD PMID:29444456 Map3k5 Rat 4-vinylcyclohexene dioxide increases expression EXP 6480464 4-vinyl-1-cyclohexene dioxide results in increased expression of MAP3K5 mRNA CTD PMID:23274565 Map3k5 Rat 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of MAP3K5 mRNA CTD PMID:24780913 more ... Map3k5 Rat aflatoxin B1 affects expression ISO MAP3K5 (Homo sapiens) 6480464 Aflatoxin B1 affects the expression of MAP3K5 protein CTD PMID:20106945 Map3k5 Rat aflatoxin B1 decreases expression ISO MAP3K5 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased expression of MAP3K5 mRNA CTD PMID:27153756 Map3k5 Rat aldehydo-D-glucose multiple interactions ISO Map3k5 (Mus musculus) 6480464 [[[[Glucose results in decreased expression of MIR17 mRNA] which results in increased expression of TXNIP mRNA] which results in increased expression of TXNIP protein] promotes the reaction [TXNIP protein binds to TXN1 protein]] which results in increased activity of MAP3K5 protein more ... CTD PMID:26660634 Map3k5 Rat aldehydo-D-glucose increases expression ISO MAP3K5 (Homo sapiens) 6480464 Glucose results in increased expression of MAP3K5 protein CTD PMID:16731828 Map3k5 Rat aldehydo-D-glucose multiple interactions ISO MAP3K5 (Homo sapiens) 6480464 Glucose deficiency promotes the reaction [DAXX protein binds to MAP3K5 protein] and Glucose results in increased phosphorylation of and results in increased activity of MAP3K5 protein CTD PMID:14505347 and PMID:16731828 Map3k5 Rat all-trans-retinoic acid decreases expression ISO Map3k5 (Mus musculus) 6480464 Tretinoin results in decreased expression of MAP3K5 mRNA CTD PMID:22498432 Map3k5 Rat all-trans-retinoic acid increases expression ISO MAP3K5 (Homo sapiens) 6480464 Tretinoin results in increased expression of MAP3K5 mRNA CTD PMID:21934132 and PMID:23724009 Map3k5 Rat andrographolide multiple interactions ISO MAP3K5 (Homo sapiens) 6480464 andrographolide inhibits the reaction [VEGFA protein results in increased phosphorylation of MAP3K5 protein] CTD PMID:24814888 Map3k5 Rat antirheumatic drug decreases expression ISO MAP3K5 (Homo sapiens) 6480464 Antirheumatic Agents results in decreased expression of MAP3K5 mRNA CTD PMID:24449571 Map3k5 Rat aristolochic acid A decreases expression ISO MAP3K5 (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of MAP3K5 mRNA CTD PMID:33212167 Map3k5 Rat belinostat decreases expression ISO MAP3K5 (Homo sapiens) 6480464 belinostat results in decreased expression of MAP3K5 mRNA CTD PMID:27188386 Map3k5 Rat benzene increases expression ISO MAP3K5 (Homo sapiens) 6480464 Benzene results in increased expression of MAP3K5 mRNA CTD PMID:33064461 Map3k5 Rat benzo[a]pyrene decreases expression ISO MAP3K5 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of MAP3K5 mRNA CTD PMID:20064835 Map3k5 Rat benzo[a]pyrene increases methylation ISO Map3k5 (Mus musculus) 6480464 Benzo(a)pyrene results in increased methylation of MAP3K5 intron CTD PMID:27901495 Map3k5 Rat benzo[a]pyrene decreases expression ISO Map3k5 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of MAP3K5 mRNA CTD PMID:19770486 Map3k5 Rat benzo[a]pyrene diol epoxide I decreases expression ISO MAP3K5 (Homo sapiens) 6480464 7 more ... CTD PMID:19150397 Map3k5 Rat berberine multiple interactions ISO Map3k5 (Mus musculus) 6480464 Berberine inhibits the reaction [[lipopolysaccharide and Escherichia coli O111 B4 co-treated with TNF protein] results in decreased expression of and results in increased phosphorylation of MAP3K5 protein] CTD PMID:30240693 Map3k5 Rat bicuculline multiple interactions ISO Map3k5 (Mus musculus) 6480464 [Bicuculline co-treated with Ethanol] results in increased expression of MAP3K5 protein CTD PMID:29044621 Map3k5 Rat bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of MAP3K5 mRNA CTD PMID:26496021 Map3k5 Rat bisphenol A multiple interactions ISO MAP3K5 (Homo sapiens) 6480464 1 more ... CTD PMID:33039870 Map3k5 Rat bisphenol A increases phosphorylation ISO MAP3K5 (Homo sapiens) 6480464 bisphenol A results in increased phosphorylation of MAP3K5 protein CTD PMID:33039870 Map3k5 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of MAP3K5 mRNA CTD PMID:25181051 more ... Map3k5 Rat bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of MAP3K5 mRNA CTD PMID:25461909 Map3k5 Rat bromobenzene increases expression EXP 6480464 bromobenzene results in increased expression of MAP3K5 mRNA CTD PMID:32479839 Map3k5 Rat cadmium dichloride multiple interactions ISO MAP3K5 (Homo sapiens) 6480464 18alpha-glycyrrhetinic acid inhibits the reaction [Cadmium Chloride results in increased expression of MAP3K5 protein] more ... CTD PMID:18703135 and PMID:29444456 Map3k5 Rat cadmium dichloride decreases expression ISO MAP3K5 (Homo sapiens) 6480464 Cadmium Chloride results in decreased expression of MAP3K5 mRNA CTD PMID:38568856 Map3k5 Rat cadmium dichloride increases expression ISO MAP3K5 (Homo sapiens) 6480464 Cadmium Chloride results in increased expression of MAP3K5 mRNA and Cadmium Chloride results in increased expression of MAP3K5 protein CTD PMID:29444456 and PMID:38382870 Map3k5 Rat cadmium dichloride increases phosphorylation EXP 6480464 Cadmium Chloride results in increased phosphorylation of MAP3K5 protein CTD PMID:18021293 and PMID:18703135 Map3k5 Rat cadmium dichloride increases activity ISO MAP3K5 (Homo sapiens) 6480464 Cadmium Chloride results in increased activity of MAP3K5 protein CTD PMID:16337887 Map3k5 Rat cadmium dichloride multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAP3K5 protein] CTD PMID:18703135 Map3k5 Rat cadmium dichloride increases phosphorylation ISO MAP3K5 (Homo sapiens) 6480464 Cadmium Chloride results in increased phosphorylation of MAP3K5 protein CTD PMID:18703135 Map3k5 Rat cadmium sulfide decreases expression ISO MAP3K5 (Homo sapiens) 6480464 cadmium sulfide results in decreased expression of MAP3K5 mRNA CTD PMID:27866839 Map3k5 Rat calcitriol multiple interactions ISO MAP3K5 (Homo sapiens) 6480464 [Calcitriol promotes the reaction [TXNIP protein binds to TNPO1 protein]] which results in increased activity of MAP3K5 protein CTD PMID:10843682 Map3k5 Rat calcitriol increases activity ISO MAP3K5 (Homo sapiens) 6480464 Calcitriol results in increased activity of MAP3K5 protein CTD PMID:10843682 Map3k5 Rat camptothecin decreases expression ISO MAP3K5 (Homo sapiens) 6480464 Camptothecin results in decreased expression of MAP3K5 mRNA CTD PMID:17374387 Map3k5 Rat cannabidiol decreases expression ISO Map3k5 (Mus musculus) 6480464 Cannabidiol results in decreased expression of MAP3K5 mRNA CTD PMID:33019509 Map3k5 Rat cannabidiol multiple interactions ISO MAP3K5 (Homo sapiens) 6480464 [Cannabidiol co-treated with moringin] results in increased expression of MAP3K5 mRNA CTD PMID:30096889 Map3k5 Rat cannabigerol decreases expression ISO Map3k5 (Mus musculus) 6480464 cannabigerol results in decreased expression of MAP3K5 mRNA CTD PMID:33019509 Map3k5 Rat carbon nanotube decreases expression ISO Map3k5 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 Map3k5 Rat Carnosol multiple interactions ISO Map3k5 (Mus musculus) 6480464 carnosol inhibits the reaction [Dietary Fats results in increased expression of MAP3K5 protein] more ... CTD PMID:34678374 Map3k5 Rat chenodeoxycholic acid multiple interactions ISO MAP3K5 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of MAP3K5 mRNA and [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of MAP3K5 mRNA CTD PMID:33819548 Map3k5 Rat chloroethene decreases expression ISO Map3k5 (Mus musculus) 6480464 Vinyl Chloride results in decreased expression of MAP3K5 mRNA CTD PMID:18579281 Map3k5 Rat chromium(6+) multiple interactions ISO MAP3K5 (Homo sapiens) 6480464 chromium hexavalent ion inhibits the reaction [TXN protein binds to MAP3K5 protein] CTD PMID:19703554 Map3k5 Rat ciguatoxin CTX1B affects expression ISO Map3k5 (Mus musculus) 6480464 Ciguatoxins affects the expression of MAP3K5 mRNA CTD PMID:18353800 Map3k5 Rat cisplatin decreases expression ISO MAP3K5 (Homo sapiens) 6480464 Cisplatin results in decreased expression of MAP3K5 mRNA CTD PMID:19561079 and PMID:27392435 Map3k5 Rat cisplatin multiple interactions ISO Map3k5 (Mus musculus) 6480464 Curcumin inhibits the reaction [Cisplatin results in increased phosphorylation of MAP3K5 protein] CTD PMID:36178099 Map3k5 Rat cisplatin increases phosphorylation ISO Map3k5 (Mus musculus) 6480464 Cisplatin results in increased phosphorylation of MAP3K5 protein CTD PMID:36178099 Map3k5 Rat cisplatin multiple interactions ISO MAP3K5 (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of MAP3K5 mRNA CTD PMID:27392435 Map3k5 Rat copper atom multiple interactions ISO MAP3K5 (Homo sapiens) 6480464 [Chelating Agents binds to Copper] which results in decreased expression of MAP3K5 mRNA and [NSC 689534 binds to Copper] which results in decreased expression of MAP3K5 mRNA CTD PMID:20971185 and PMID:30911355 Map3k5 Rat copper(0) multiple interactions ISO MAP3K5 (Homo sapiens) 6480464 [Chelating Agents binds to Copper] which results in decreased expression of MAP3K5 mRNA and [NSC 689534 binds to Copper] which results in decreased expression of MAP3K5 mRNA CTD PMID:20971185 and PMID:30911355 Map3k5 Rat copper(II) chloride decreases expression ISO MAP3K5 (Homo sapiens) 6480464 cupric chloride results in decreased expression of MAP3K5 mRNA CTD PMID:38568856 Map3k5 Rat copper(II) sulfate decreases expression ISO Map3k5 (Mus musculus) 6480464 Copper Sulfate results in decreased expression of MAP3K5 mRNA CTD PMID:18579281 Map3k5 Rat crocidolite asbestos affects expression ISO MAP3K5 (Homo sapiens) 6480464 Asbestos and Crocidolite affects the expression of MAP3K5 mRNA CTD PMID:17331233 Map3k5 Rat curcumin increases phosphorylation ISO MAP3K5 (Homo sapiens) 150429751 Curcumin increases phosphorylation of MAP3K5 protein in uterine cervix RGD Map3k5 Rat curcumin multiple interactions ISO Map3k5 (Mus musculus) 6480464 Curcumin inhibits the reaction [Cisplatin results in increased phosphorylation of MAP3K5 protein] CTD PMID:36178099 Map3k5 Rat D-glucose increases expression ISO MAP3K5 (Homo sapiens) 6480464 Glucose results in increased expression of MAP3K5 protein CTD PMID:16731828 Map3k5 Rat D-glucose multiple interactions ISO Map3k5 (Mus musculus) 6480464 [[[[Glucose results in decreased expression of MIR17 mRNA] which results in increased expression of TXNIP mRNA] which results in increased expression of TXNIP protein] promotes the reaction [TXNIP protein binds to TXN1 protein]] which results in increased activity of MAP3K5 protein more ... CTD PMID:26660634 Map3k5 Rat D-glucose multiple interactions ISO MAP3K5 (Homo sapiens) 6480464 Glucose deficiency promotes the reaction [DAXX protein binds to MAP3K5 protein] and Glucose results in increased phosphorylation of and results in increased activity of MAP3K5 protein CTD PMID:14505347 and PMID:16731828 Map3k5 Rat daunorubicin decreases expression ISO MAP3K5 (Homo sapiens) 6480464 Daunorubicin results in decreased expression of MAP3K5 mRNA CTD PMID:17374387 Map3k5 Rat deoxycholic acid multiple interactions ISO MAP3K5 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of MAP3K5 mRNA and [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of MAP3K5 mRNA CTD PMID:33819548 Map3k5 Rat deoxynivalenol increases phosphorylation ISO MAP3K5 (Homo sapiens) 6480464 deoxynivalenol results in increased phosphorylation of MAP3K5 protein CTD PMID:20181660 Map3k5 Rat deoxynivalenol multiple interactions ISO MAP3K5 (Homo sapiens) 6480464 AG 1879 inhibits the reaction [deoxynivalenol results in increased phosphorylation of MAP3K5 protein] CTD PMID:20181660 Map3k5 Rat desferrioxamine B multiple interactions ISO MAP3K5 (Homo sapiens) 6480464 Deferoxamine inhibits the reaction [Plant Extracts results in increased phosphorylation of MAP3K5 protein] CTD PMID:20206247 Map3k5 Rat Dibutyl phosphate affects expression ISO MAP3K5 (Homo sapiens) 6480464 di-n-butylphosphoric acid affects the expression of MAP3K5 mRNA CTD PMID:37042841 Map3k5 Rat dieldrin affects methylation ISO Map3k5 (Mus musculus) 6480464 Dieldrin affects the methylation of MAP3K5 gene CTD PMID:38995845 Map3k5 Rat dimethyl sulfoxide multiple interactions EXP 6480464 Dimethyl Sulfoxide inhibits the reaction [Thioacetamide results in increased activity of MAP3K5 protein] CTD PMID:12370186 Map3k5 Rat dimethyl sulfoxide decreases activity EXP 6480464 Dimethyl Sulfoxide results in decreased activity of MAP3K5 protein CTD PMID:12370186 Map3k5 Rat dimethylarsinic acid increases expression ISO Map3k5 (Mus musculus) 6480464 Cacodylic Acid results in increased expression of MAP3K5 mRNA CTD PMID:17441966 Map3k5 Rat disodium selenite multiple interactions ISO Map3k5 (Mus musculus) 6480464 Sodium Selenite promotes the reaction [[Streptozocin co-treated with Dietary Fats] results in increased phosphorylation of MAP3K5 protein] CTD PMID:26522834 Map3k5 Rat dorsomorphin multiple interactions ISO MAP3K5 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 Map3k5 Rat doxorubicin multiple interactions ISO Map3k5 (Mus musculus) 6480464 PSMB10 protein inhibits the reaction [Doxorubicin results in increased expression of MAP3K5 protein] more ... CTD PMID:25896364 Map3k5 Rat doxorubicin decreases expression ISO MAP3K5 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of MAP3K5 mRNA CTD PMID:29803840 Map3k5 Rat doxorubicin increases expression ISO Map3k5 (Mus musculus) 6480464 Doxorubicin results in increased expression of MAP3K5 protein CTD PMID:25896364 Map3k5 Rat edaravone decreases activity ISO Map3k5 (Mus musculus) 6480464 Edaravone results in decreased activity of MAP3K5 protein CTD PMID:15824197 Map3k5 Rat efavirenz increases phosphorylation ISO MAP3K5 (Homo sapiens) 6480464 efavirenz metabolite results in increased phosphorylation of MAP3K5 protein and efavirenz results in increased phosphorylation of MAP3K5 protein CTD PMID:21958719 Map3k5 Rat elemental selenium decreases expression ISO MAP3K5 (Homo sapiens) 6480464 Selenium results in decreased expression of MAP3K5 mRNA CTD PMID:19244175 Map3k5 Rat endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of MAP3K5 mRNA CTD PMID:29391264 and PMID:31464424 Map3k5 Rat entinostat increases expression ISO MAP3K5 (Homo sapiens) 6480464 entinostat results in increased expression of MAP3K5 mRNA CTD PMID:26272509 Map3k5 Rat entinostat multiple interactions ISO MAP3K5 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAP3K5 mRNA CTD PMID:27188386 Map3k5 Rat ethanol multiple interactions ISO Map3k5 (Mus musculus) 6480464 [Bicuculline co-treated with Ethanol] results in increased expression of MAP3K5 protein more ... CTD PMID:29044621 Map3k5 Rat ethanol increases expression ISO Map3k5 (Mus musculus) 6480464 Ethanol results in increased expression of MAP3K5 protein CTD PMID:29044621 Map3k5 Rat ethyl methanesulfonate decreases expression ISO MAP3K5 (Homo sapiens) 6480464 Ethyl Methanesulfonate results in decreased expression of MAP3K5 mRNA CTD PMID:23649840 Map3k5 Rat etoposide decreases expression ISO MAP3K5 (Homo sapiens) 6480464 Etoposide results in decreased expression of MAP3K5 mRNA CTD PMID:17374387 Map3k5 Rat fingolimod hydrochloride multiple interactions ISO Map3k5 (Mus musculus) 6480464 [lipopolysaccharide and Escherichia coli O111 B4 co-treated with Okadaic Acid co-treated with Fingolimod Hydrochloride] results in increased expression of MAP3K5 mRNA CTD PMID:33069748 Map3k5 Rat flutamide increases expression ISO Map3k5 (Mus musculus) 6480464 Flutamide results in increased expression of MAP3K5 mRNA CTD PMID:32662666 Map3k5 Rat folic acid decreases expression ISO Map3k5 (Mus musculus) 6480464 Folic Acid results in decreased expression of MAP3K5 mRNA CTD PMID:25629700 Map3k5 Rat formaldehyde decreases expression ISO MAP3K5 (Homo sapiens) 6480464 Formaldehyde results in decreased expression of MAP3K5 mRNA CTD PMID:23416264 Map3k5 Rat furan increases expression EXP 6480464 furan results in increased expression of MAP3K5 mRNA CTD PMID:26194646 Map3k5 Rat furan multiple interactions ISO Map3k5 (Mus musculus) 6480464 rhodioloside inhibits the reaction [furan results in increased phosphorylation of MAP3K5 protein] CTD PMID:34450210 Map3k5 Rat furan increases phosphorylation ISO Map3k5 (Mus musculus) 6480464 furan results in increased phosphorylation of MAP3K5 protein CTD PMID:34450210 Map3k5 Rat gamma-aminobutyric acid multiple interactions ISO Map3k5 (Mus musculus) 6480464 gamma-Aminobutyric Acid inhibits the reaction [Ethanol results in increased expression of MAP3K5 protein] CTD PMID:29044621 Map3k5 Rat geldanamycin increases expression ISO MAP3K5 (Homo sapiens) 6480464 geldanamycin results in increased expression of MAP3K5 mRNA CTD PMID:26705709 Map3k5 Rat gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of MAP3K5 mRNA CTD PMID:33387578 Map3k5 Rat glucose increases expression ISO MAP3K5 (Homo sapiens) 6480464 Glucose results in increased expression of MAP3K5 protein CTD PMID:16731828 Map3k5 Rat glucose multiple interactions ISO Map3k5 (Mus musculus) 6480464 [[[[Glucose results in decreased expression of MIR17 mRNA] which results in increased expression of TXNIP mRNA] which results in increased expression of TXNIP protein] promotes the reaction [TXNIP protein binds to TXN1 protein]] which results in increased activity of MAP3K5 protein more ... CTD PMID:26660634 Map3k5 Rat glucose multiple interactions ISO MAP3K5 (Homo sapiens) 6480464 Glucose deficiency promotes the reaction [DAXX protein binds to MAP3K5 protein] and Glucose results in increased phosphorylation of and results in increased activity of MAP3K5 protein CTD PMID:14505347 and PMID:16731828 Map3k5 Rat glycochenodeoxycholic acid multiple interactions ISO MAP3K5 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of MAP3K5 mRNA and [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of MAP3K5 mRNA CTD PMID:33819548 Map3k5 Rat glycocholic acid multiple interactions ISO MAP3K5 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of MAP3K5 mRNA and [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of MAP3K5 mRNA CTD PMID:33819548 Map3k5 Rat glycodeoxycholic acid multiple interactions ISO MAP3K5 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of MAP3K5 mRNA and [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of MAP3K5 mRNA CTD PMID:33819548 Map3k5 Rat glycyrrhetinate multiple interactions ISO MAP3K5 (Homo sapiens) 6480464 18alpha-glycyrrhetinic acid inhibits the reaction [Cadmium Chloride results in increased expression of MAP3K5 protein] CTD PMID:29444456 Map3k5 Rat glycyrrhetinic acid multiple interactions ISO MAP3K5 (Homo sapiens) 6480464 18alpha-glycyrrhetinic acid inhibits the reaction [Cadmium Chloride results in increased expression of MAP3K5 protein] CTD PMID:29444456 Map3k5 Rat hexadecanoic acid increases expression ISO Map3k5 (Mus musculus) 6480464 Palmitic Acid results in increased expression of MAP3K5 protein CTD PMID:34678374 Map3k5 Rat hexadecanoic acid multiple interactions ISO Map3k5 (Mus musculus) 6480464 carnosol inhibits the reaction [Palmitic Acid results in increased expression of MAP3K5 protein] more ... CTD PMID:34678374 Map3k5 Rat hydrogen peroxide increases activity EXP 6480464 Hydrogen Peroxide results in increased activity of MAP3K5 protein CTD PMID:15629441 Map3k5 Rat hydrogen peroxide multiple interactions ISO MAP3K5 (Homo sapiens) 6480464 ASK1 protein inhibits the reaction [Hydrogen Peroxide promotes the reaction [MAP3K5 protein binds to MAP2K7 protein]] and Hydrogen Peroxide promotes the reaction [MAP3K5 protein binds to MAP2K7 protein] CTD PMID:28939911 Map3k5 Rat hydrogen peroxide increases expression EXP 6480464 Hydrogen Peroxide results in increased expression of MAP3K5 protein CTD PMID:16157298 Map3k5 Rat indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of MAP3K5 mRNA CTD PMID:21396975 Map3k5 Rat indole-3-methanol multiple interactions ISO MAP3K5 (Homo sapiens) 6480464 Acetylcysteine inhibits the reaction [indole-3-carbinol results in decreased expression of and results in increased phosphorylation of MAP3K5 protein] and indole-3-carbinol results in decreased expression of and results in increased phosphorylation of MAP3K5 protein CTD PMID:33118390 Map3k5 Rat inulin multiple interactions ISO Map3k5 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of MAP3K5 mRNA CTD PMID:36331819 Map3k5 Rat irinotecan decreases expression ISO MAP3K5 (Homo sapiens) 6480464 Irinotecan metabolite results in decreased expression of MAP3K5 mRNA and Irinotecan results in decreased expression of MAP3K5 mRNA CTD PMID:15956246 Map3k5 Rat isoprenaline decreases expression ISO Map3k5 (Mus musculus) 6480464 Isoproterenol results in decreased expression of MAP3K5 mRNA CTD PMID:21335049 Map3k5 Rat kainic acid decreases expression ISO Map3k5 (Mus musculus) 6480464 Kainic Acid results in decreased expression of MAP3K5 mRNA CTD PMID:17997037 Map3k5 Rat KN-93 multiple interactions EXP 6480464 KN 93 inhibits the reaction [Phenylephrine results in increased activity of MAP3K5 protein] CTD PMID:15629441 Map3k5 Rat L-1,4-dithiothreitol multiple interactions ISO MAP3K5 (Homo sapiens) 6480464 Dithiothreitol inhibits the reaction [NCX 4040 inhibits the reaction [TXN1 protein binds to MAP3K5 protein]] CTD PMID:18922898 Map3k5 Rat L-ascorbic acid multiple interactions ISO MAP3K5 (Homo sapiens) 6480464 Ascorbic Acid inhibits the reaction [Plant Extracts results in increased phosphorylation of MAP3K5 protein] CTD PMID:20206247 Map3k5 Rat lactulose multiple interactions EXP 6480464 Lactulose inhibits the reaction [Thioacetamide results in increased expression of MAP3K5 protein] CTD PMID:35961375 Map3k5 Rat lead diacetate multiple interactions EXP 6480464 [lead acetate results in increased abundance of Lead] which results in decreased expression of MAP3K5 mRNA CTD PMID:36642386 Map3k5 Rat lead(0) multiple interactions EXP 6480464 [lead acetate results in increased abundance of Lead] which results in decreased expression of MAP3K5 mRNA CTD PMID:36642386 Map3k5 Rat lenvatinib increases expression EXP 6480464 lenvatinib results in increased expression of MAP3K5 mRNA CTD PMID:34019861 Map3k5 Rat lipopolysaccharide increases response to substance ISO Map3k5 (Mus musculus) 6480464 MAP3K5 protein results in increased susceptibility to Lipopolysaccharides CTD PMID:21449566 Map3k5 Rat lipopolysaccharide increases expression ISO MAP3K5 (Homo sapiens) 6480464 Lipopolysaccharides results in increased expression of MAP3K5 mRNA CTD PMID:35811015 Map3k5 Rat lipopolysaccharide multiple interactions ISO MAP3K5 (Homo sapiens) 6480464 [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of MAP3K5 mRNA CTD PMID:35811015 Map3k5 Rat LY 379268 increases phosphorylation EXP 6480464 LY 379268 results in increased phosphorylation of MAP3K5 protein CTD PMID:17293559 Map3k5 Rat mancozeb increases expression ISO Map3k5 (Mus musculus) 6480464 mancozeb results in increased expression of MAP3K5 mRNA CTD PMID:36007320 Map3k5 Rat mercury dibromide multiple interactions ISO MAP3K5 (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAP3K5 mRNA CTD PMID:27188386 Map3k5 Rat mercury dichloride increases activity ISO MAP3K5 (Homo sapiens) 6480464 Mercuric Chloride results in increased activity of MAP3K5 protein CTD PMID:16337887 Map3k5 Rat methimazole decreases expression EXP 6480464 Methimazole results in decreased expression of MAP3K5 mRNA CTD PMID:30047161 Map3k5 Rat methyl methanesulfonate decreases expression ISO MAP3K5 (Homo sapiens) 6480464 Methyl Methanesulfonate results in decreased expression of MAP3K5 mRNA CTD PMID:23649840 Map3k5 Rat MK-2206 multiple interactions ISO MAP3K5 (Homo sapiens) 6480464 MK 2206 promotes the reaction [Cadmium Chloride results in increased expression of MAP3K5 protein] CTD PMID:29444456 Map3k5 Rat muscimol multiple interactions ISO Map3k5 (Mus musculus) 6480464 Muscimol inhibits the reaction [Ethanol results in increased expression of MAP3K5 protein] CTD PMID:29044621 Map3k5 Rat N-acetyl-L-cysteine multiple interactions ISO Map3k5 (Mus musculus) 6480464 Acetylcysteine inhibits the reaction [Rotenone inhibits the reaction [TXN protein binds to and results in decreased activity of MAP3K5 protein]] CTD PMID:16449798 Map3k5 Rat N-acetyl-L-cysteine multiple interactions ISO MAP3K5 (Homo sapiens) 150429751 N-acetyl-L-cysteine co-treated with Curcumin increases phosphorylation of MAP3K5 protein in uterine cervix RGD Map3k5 Rat N-acetyl-L-cysteine multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAP3K5 protein] CTD PMID:18703135 Map3k5 Rat N-acetyl-L-cysteine multiple interactions ISO MAP3K5 (Homo sapiens) 6480464 Acetylcysteine inhibits the reaction [bisphenol A results in increased phosphorylation of MAP3K5 protein] more ... CTD PMID:18703135 more ... Map3k5 Rat N-acetylsphingosine multiple interactions ISO MAP3K5 (Homo sapiens) 6480464 N-acetylsphingosine affects the phosphorylation of and results in increased activity of MAP3K5 protein and TXNIP affects the reaction [N-acetylsphingosine affects the phosphorylation of and results in increased activity of MAP3K5 protein] CTD PMID:18270325 Map3k5 Rat N-methyl-4-phenylpyridinium increases phosphorylation ISO MAP3K5 (Homo sapiens) 6480464 1-Methyl-4-phenylpyridinium results in increased phosphorylation of MAP3K5 protein CTD PMID:20946892 Map3k5 Rat N-methyl-4-phenylpyridinium increases expression ISO MAP3K5 (Homo sapiens) 6480464 1-Methyl-4-phenylpyridinium results in increased expression of MAP3K5 protein CTD PMID:34732784 Map3k5 Rat N-methyl-4-phenylpyridinium increases phosphorylation EXP 6480464 1-Methyl-4-phenylpyridinium results in increased phosphorylation of MAP3K5 protein CTD PMID:28939911 Map3k5 Rat N-methyl-4-phenylpyridinium multiple interactions EXP 6480464 1-Methyl-4-phenylpyridinium promotes the reaction [MAP3K5 protein binds to MAP2K7 protein] more ... CTD PMID:28939911 Map3k5 Rat N-methyl-4-phenylpyridinium increases expression ISO Map3k5 (Mus musculus) 6480464 1-Methyl-4-phenylpyridinium results in increased expression of MAP3K5 protein CTD PMID:28939911 Map3k5 Rat N-methyl-4-phenylpyridinium multiple interactions ISO MAP3K5 (Homo sapiens) 6480464 1-methylpropyl-2-imidazolyl disulfide inhibits the reaction [schisanhenol inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of MAP3K5 protein]] more ... CTD PMID:20946892 and PMID:34732784 Map3k5 Rat N-methyl-4-phenylpyridinium decreases expression ISO MAP3K5 (Homo sapiens) 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of MAP3K5 mRNA CTD PMID:25234470 Map3k5 Rat neoechinulin A multiple interactions ISO Map3k5 (Mus musculus) 6480464 neoechinulin A inhibits the reaction [[APP protein binds to APP protein binds to APP protein] which results in increased phosphorylation of MAP3K5 protein] CTD PMID:23261590 Map3k5 Rat nickel subsulfide affects response to substance ISO MAP3K5 (Homo sapiens) 6480464 MAP3K5 protein affects the susceptibility to nickel subsulfide CTD PMID:20112989 Map3k5 Rat nickel subsulfide multiple interactions ISO MAP3K5 (Homo sapiens) 6480464 nickel subsulfide results in increased phosphorylation of and results in increased activity of MAP3K5 protein CTD PMID:20112989 Map3k5 Rat nickel sulfate increases expression ISO MAP3K5 (Homo sapiens) 6480464 nickel sulfate results in increased expression of MAP3K5 mRNA CTD PMID:22714537 Map3k5 Rat Nor-9-carboxy-delta9-THC multiple interactions ISO MAP3K5 (Homo sapiens) 6480464 [Cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which affects the methylation of MAP3K5 gene CTD PMID:30521419 Map3k5 Rat obeticholic acid decreases expression ISO MAP3K5 (Homo sapiens) 6480464 obeticholic acid results in decreased expression of MAP3K5 mRNA CTD PMID:27939613 Map3k5 Rat okadaic acid multiple interactions ISO Map3k5 (Mus musculus) 6480464 [lipopolysaccharide and Escherichia coli O111 B4 co-treated with Okadaic Acid co-treated with Fingolimod Hydrochloride] results in increased expression of MAP3K5 mRNA CTD PMID:33069748 Map3k5 Rat ozone multiple interactions ISO MAP3K5 (Homo sapiens) 6480464 [Air Pollutants results in increased abundance of Ozone] which affects the expression of MAP3K5 mRNA CTD PMID:35430440 Map3k5 Rat paclitaxel multiple interactions ISO MAP3K5 (Homo sapiens) 6480464 MAP3K5 protein affects the reaction [Paclitaxel results in increased activity of CASP3 protein] and MAP3K5 protein affects the reaction [Paclitaxel results in increased cleavage of PARP1 protein] CTD PMID:10075725 Map3k5 Rat paracetamol multiple interactions ISO Map3k5 (Mus musculus) 6480464 MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of ACTG1 mRNA] more ... CTD PMID:18700144 Map3k5 Rat paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of MAP3K5 mRNA CTD PMID:33387578 Map3k5 Rat paracetamol multiple interactions ISO MAP3K5 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of MAP3K5 mRNA CTD PMID:33819548 Map3k5 Rat paracetamol decreases expression ISO MAP3K5 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of MAP3K5 mRNA CTD PMID:21420995 and PMID:29067470 Map3k5 Rat paracetamol increases response to substance ISO Map3k5 (Mus musculus) 6480464 MAP3K5 protein results in increased susceptibility to Acetaminophen CTD PMID:18700144 Map3k5 Rat paracetamol increases activity ISO Map3k5 (Mus musculus) 6480464 Acetaminophen results in increased activity of MAP3K5 protein CTD PMID:18700144 Map3k5 Rat paraquat multiple interactions ISO MAP3K5 (Homo sapiens) 6480464 [Paraquat co-treated with MAP3K5 protein] results in increased degradation of SQSTM1 protein more ... CTD PMID:19735704 and PMID:20929985 Map3k5 Rat perfluorooctane-1-sulfonic acid increases expression ISO Map3k5 (Mus musculus) 6480464 perfluorooctane sulfonic acid results in increased expression of MAP3K5 mRNA CTD PMID:26300304 Map3k5 Rat perfluorooctane-1-sulfonic acid multiple interactions ISO Map3k5 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of MAP3K5 mRNA and [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of MAP3K5 mRNA CTD PMID:36331819 Map3k5 Rat phenobarbital increases expression ISO Map3k5 (Mus musculus) 6480464 Phenobarbital results in increased expression of MAP3K5 mRNA CTD PMID:19270015 Map3k5 Rat phenylephrine multiple interactions EXP 6480464 CAMK2D protein promotes the reaction [Phenylephrine results in increased activity of MAP3K5 protein] and KN 93 inhibits the reaction [Phenylephrine results in increased activity of MAP3K5 protein] CTD PMID:15629441 Map3k5 Rat phenylephrine increases activity EXP 6480464 Phenylephrine results in increased activity of MAP3K5 protein CTD PMID:15629441 Map3k5 Rat phenylmercury acetate increases expression ISO MAP3K5 (Homo sapiens) 6480464 Phenylmercuric Acetate results in increased expression of MAP3K5 mRNA CTD PMID:26272509 Map3k5 Rat phenylmercury acetate multiple interactions ISO MAP3K5 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAP3K5 mRNA CTD PMID:27188386 Map3k5 Rat pirinixic acid increases expression ISO Map3k5 (Mus musculus) 6480464 pirinixic acid results in increased expression of MAP3K5 mRNA CTD PMID:18445702 Map3k5 Rat platycodin D multiple interactions ISO MAP3K5 (Homo sapiens) 6480464 Acetylcysteine inhibits the reaction [platycodin D affects the phosphorylation of and results in increased activity of MAP3K5 protein] and platycodin D affects the phosphorylation of and results in increased activity of MAP3K5 protein CTD PMID:22784044 Map3k5 Rat potassium chromate increases expression ISO MAP3K5 (Homo sapiens) 6480464 potassium chromate(VI) results in increased expression of MAP3K5 mRNA CTD PMID:22714537 Map3k5 Rat pregnenolone 16alpha-carbonitrile increases expression ISO Map3k5 (Mus musculus) 6480464 Pregnenolone Carbonitrile results in increased expression of MAP3K5 mRNA CTD PMID:28903501 Map3k5 Rat procymidone increases expression ISO Map3k5 (Mus musculus) 6480464 procymidone results in increased expression of MAP3K5 mRNA CTD PMID:35913088 Map3k5 Rat protein kinase inhibitor multiple interactions ISO MAP3K5 (Homo sapiens) 6480464 Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of MAP3K5 mRNA] CTD PMID:28003376 Map3k5 Rat quercetin multiple interactions ISO MAP3K5 (Homo sapiens) 6480464 Acetylcysteine inhibits the reaction [Quercetin results in decreased phosphorylation of and results in increased activity of MAP3K5 protein] and Quercetin results in decreased phosphorylation of and results in increased activity of MAP3K5 protein CTD PMID:20083342 Map3k5 Rat rac-lactic acid decreases expression ISO MAP3K5 (Homo sapiens) 6480464 Lactic Acid results in decreased expression of MAP3K5 mRNA CTD PMID:30851411 Map3k5 Rat raloxifene multiple interactions ISO MAP3K5 (Homo sapiens) 6480464 [Raloxifene Hydrochloride co-treated with ESR2 protein] results in decreased expression of MAP3K5 mRNA CTD PMID:19059307 Map3k5 Rat reactive oxygen species multiple interactions ISO Map3k5 (Mus musculus) 6480464 Reactive Oxygen Species affects the reaction [TXN protein binds to and results in decreased activity of MAP3K5 protein] CTD PMID:16449798 Map3k5 Rat resveratrol increases activity ISO MAP3K5 (Homo sapiens) 6480464 resveratrol results in increased activity of MAP3K5 protein CTD PMID:15217905 Map3k5 Rat resveratrol multiple interactions ISO MAP3K5 (Homo sapiens) 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of MAP3K5 mRNA CTD PMID:23557933 Map3k5 Rat resveratrol multiple interactions EXP 6480464 resveratrol inhibits the reaction [Streptozocin results in increased expression of MAP3K5 protein] CTD PMID:26499206 Map3k5 Rat rotenone multiple interactions ISO Map3k5 (Mus musculus) 6480464 Acetylcysteine inhibits the reaction [Rotenone inhibits the reaction [TXN protein binds to and results in decreased activity of MAP3K5 protein]] and Rotenone inhibits the reaction [TXN protein binds to and results in decreased activity of MAP3K5 protein] CTD PMID:16449798 Map3k5 Rat rotenone increases expression EXP 6480464 Rotenone results in increased expression of MAP3K5 mRNA CTD PMID:28374803 Map3k5 Rat S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO MAP3K5 (Homo sapiens) 6480464 [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of MAP3K5 mRNA CTD PMID:35811015 Map3k5 Rat Salidroside multiple interactions ISO Map3k5 (Mus musculus) 6480464 rhodioloside inhibits the reaction [furan results in increased phosphorylation of MAP3K5 protein] CTD PMID:34450210 Map3k5 Rat salubrinal affects response to substance ISO MAP3K5 (Homo sapiens) 6480464 salubrinal affects the susceptibility to MAP3K5 protein CTD PMID:20929985 Map3k5 Rat salubrinal multiple interactions ISO MAP3K5 (Homo sapiens) 6480464 salubrinal affects the susceptibility to [Paraquat co-treated with MAP3K5 protein] more ... CTD PMID:19735704 and PMID:20929985 Map3k5 Rat SB 431542 multiple interactions ISO MAP3K5 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 Map3k5 Rat selenium atom decreases expression ISO MAP3K5 (Homo sapiens) 6480464 Selenium results in decreased expression of MAP3K5 mRNA CTD PMID:19244175 Map3k5 Rat sevoflurane increases phosphorylation ISO MAP3K5 (Homo sapiens) 6480464 sevoflurane results in increased phosphorylation of MAP3K5 protein CTD PMID:18349187 Map3k5 Rat sodium arsenite increases activity ISO MAP3K5 (Homo sapiens) 6480464 sodium arsenite results in increased activity of MAP3K5 protein CTD PMID:16337887 Map3k5 Rat sodium arsenite affects expression ISO MAP3K5 (Homo sapiens) 6480464 sodium arsenite affects the expression of MAP3K5 mRNA CTD PMID:34032870 Map3k5 Rat sodium arsenite decreases expression ISO MAP3K5 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of MAP3K5 mRNA CTD PMID:38568856 Map3k5 Rat sodium arsenite increases expression ISO MAP3K5 (Homo sapiens) 6480464 sodium arsenite results in increased expression of MAP3K5 mRNA CTD PMID:22714537 Map3k5 Rat sodium dichromate decreases expression ISO Map3k5 (Mus musculus) 6480464 sodium bichromate results in decreased expression of MAP3K5 mRNA CTD PMID:22155349 Map3k5 Rat sodium dichromate increases expression ISO Map3k5 (Mus musculus) 6480464 sodium bichromate results in increased expression of MAP3K5 mRNA CTD PMID:22155349 Map3k5 Rat streptozocin multiple interactions ISO Map3k5 (Mus musculus) 6480464 [Streptozocin co-treated with Dietary Fats] results in increased phosphorylation of MAP3K5 protein more ... CTD PMID:16731828 and PMID:26522834 Map3k5 Rat streptozocin increases expression EXP 6480464 Streptozocin results in increased expression of MAP3K5 protein CTD PMID:26499206 Map3k5 Rat streptozocin multiple interactions EXP 6480464 resveratrol inhibits the reaction [Streptozocin results in increased expression of MAP3K5 protein] CTD PMID:26499206 Map3k5 Rat succimer multiple interactions ISO Map3k5 (Mus musculus) 6480464 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MAP3K5 mRNA and [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of MAP3K5 mRNA CTD PMID:21641980 and PMID:26378955 Map3k5 Rat surfactin multiple interactions ISO MAP3K5 (Homo sapiens) 6480464 4-methylumbelliferone 8-carbaldehyde inhibits the reaction [surfactin peptide results in increased phosphorylation of MAP3K5 protein] and KIRA6 inhibits the reaction [surfactin peptide results in increased phosphorylation of MAP3K5 protein] CTD PMID:34850538 Map3k5 Rat surfactin increases phosphorylation ISO MAP3K5 (Homo sapiens) 6480464 surfactin peptide results in increased phosphorylation of MAP3K5 protein CTD PMID:34850538 Map3k5 Rat surfactin C increases phosphorylation ISO MAP3K5 (Homo sapiens) 6480464 surfactin peptide results in increased phosphorylation of MAP3K5 protein CTD PMID:34850538 Map3k5 Rat surfactin C multiple interactions ISO MAP3K5 (Homo sapiens) 6480464 4-methylumbelliferone 8-carbaldehyde inhibits the reaction [surfactin peptide results in increased phosphorylation of MAP3K5 protein] and KIRA6 inhibits the reaction [surfactin peptide results in increased phosphorylation of MAP3K5 protein] CTD PMID:34850538 Map3k5 Rat tamoxifen multiple interactions ISO MAP3K5 (Homo sapiens) 6480464 [Tamoxifen co-treated with ESR2 protein] results in decreased expression of MAP3K5 mRNA CTD PMID:19059307 Map3k5 Rat tartrazine multiple interactions ISO MAP3K5 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of MAP3K5 mRNA CTD PMID:33819548 Map3k5 Rat temozolomide increases expression ISO MAP3K5 (Homo sapiens) 6480464 Temozolomide results in increased expression of MAP3K5 mRNA CTD PMID:31758290 Map3k5 Rat teprenone multiple interactions ISO MAP3K5 (Homo sapiens) 6480464 geranylgeranylacetone inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of MAP3K5 protein] CTD PMID:34732784 Map3k5 Rat tert-butyl hydroperoxide increases expression ISO MAP3K5 (Homo sapiens) 6480464 tert-Butylhydroperoxide results in increased expression of MAP3K5 mRNA CTD PMID:15336504 Map3k5 Rat tetrachloroethene increases expression ISO Map3k5 (Mus musculus) 6480464 Tetrachloroethylene results in increased expression of MAP3K5 mRNA CTD PMID:28973375 Map3k5 Rat tetrachloromethane increases expression ISO Map3k5 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of MAP3K5 mRNA CTD PMID:31919559 Map3k5 Rat thioacetamide multiple interactions EXP 6480464 Dimethyl Sulfoxide inhibits the reaction [Thioacetamide results in increased activity of MAP3K5 protein] more ... CTD PMID:12370186 and PMID:35961375 Map3k5 Rat thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of MAP3K5 mRNA and Thioacetamide results in increased expression of MAP3K5 protein CTD PMID:23411599 and PMID:35961375 Map3k5 Rat thioacetamide increases activity EXP 6480464 Thioacetamide results in increased activity of MAP3K5 protein CTD PMID:12370186 Map3k5 Rat thiram decreases expression ISO MAP3K5 (Homo sapiens) 6480464 Thiram results in decreased expression of MAP3K5 mRNA CTD PMID:38568856 Map3k5 Rat titanium dioxide increases methylation ISO Map3k5 (Mus musculus) 6480464 titanium dioxide results in increased methylation of MAP3K5 promoter CTD PMID:35295148 Map3k5 Rat titanium dioxide decreases methylation ISO Map3k5 (Mus musculus) 6480464 titanium dioxide results in decreased methylation of MAP3K5 gene CTD PMID:35295148 Map3k5 Rat titanium dioxide increases expression ISO Map3k5 (Mus musculus) 6480464 titanium dioxide results in increased expression of MAP3K5 mRNA CTD PMID:23557971 Map3k5 Rat tributylstannane multiple interactions ISO MAP3K5 (Homo sapiens) 6480464 tributyltin results in increased expression of and results in increased phosphorylation of MAP3K5 protein CTD PMID:24038145 Map3k5 Rat trichostatin A increases expression ISO MAP3K5 (Homo sapiens) 6480464 trichostatin A results in increased expression of MAP3K5 mRNA CTD PMID:24935251 Map3k5 Rat troglitazone multiple interactions ISO MAP3K5 (Homo sapiens) 6480464 mito-carboxy proxyl inhibits the reaction [troglitazone results in increased activity of MAP3K5 protein] CTD PMID:17975114 Map3k5 Rat troglitazone increases activity ISO MAP3K5 (Homo sapiens) 6480464 troglitazone results in increased activity of MAP3K5 protein CTD PMID:17975114 Map3k5 Rat tungsten decreases expression ISO Map3k5 (Mus musculus) 6480464 Tungsten results in decreased expression of MAP3K5 mRNA CTD PMID:30912803 Map3k5 Rat tunicamycin multiple interactions ISO MAP3K5 (Homo sapiens) 6480464 Tunicamycin results in increased phosphorylation of and results in increased activity of MAP3K5 protein CTD PMID:19735704 Map3k5 Rat valproic acid affects expression ISO Map3k5 (Mus musculus) 6480464 Valproic Acid affects the expression of MAP3K5 mRNA CTD PMID:17292431 Map3k5 Rat valproic acid affects expression ISO MAP3K5 (Homo sapiens) 6480464 Valproic Acid affects the expression of MAP3K5 mRNA CTD PMID:25979313 Map3k5 Rat valproic acid increases expression ISO MAP3K5 (Homo sapiens) 6480464 Valproic Acid results in increased expression of MAP3K5 mRNA CTD PMID:23179753 more ... Map3k5 Rat valproic acid multiple interactions ISO MAP3K5 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAP3K5 mRNA CTD PMID:27188386 Map3k5 Rat vinclozolin increases methylation EXP 6480464 vinclozolin results in increased methylation of MAP3K5 gene CTD PMID:30207508 Map3k5 Rat vitamin E decreases expression ISO MAP3K5 (Homo sapiens) 6480464 Vitamin E results in decreased expression of MAP3K5 mRNA CTD PMID:19244175